Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Computational Modeling for Circulating Cell-Free DNA in Clinical Oncology.

JCO clinical cancer informatics - 1 Mar 2025

Nguyen Phuong Linh, Salas Sébastien, Benzekry Sébastien

Abstract excerpt

PURPOSE: Liquid biopsy, specifically circulating cell-free DNA (cfDNA), has emerged as a powerful tool for cancer early diagnosis, prognosis, and treatment monitoring over a wide range of cancer types. Computational modeling (CM) of cfDNA data is essential to harness its full potential for real-time, noninvasive insights into tumor biology, enhancing clinical decision making. DESIGN: This work reviews CM-cfDNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Computer Simulation

Share to Liquid Biopsy

Share to Machine Learning

Share to Medical Oncology

Source

Identifiers

PMID: 40020203
DOI: 10.1200/CCI-24-00224

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Computational Modeling for Circulating Cell-Free DNA in Clinical Oncology.PMID 40020203Read ↗

cfDNAanalyzer: a comprehensive toolkit for analyzing cell-free DNA genomic sequencing data in liquid biopsySemantic proximity Read ↗

Exploring the Role of Circulating Cell-Free DNA in Disease Diagnosis and TherapySemantic proximity Read ↗

Cancer treatment monitoring using cell-free DNA fragmentomes.Semantic proximity Read ↗

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatmentSemantic proximity Read ↗

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Semantic proximity Read ↗

Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics.Semantic proximity Read ↗

Liquid biopsies across the cancer care continuum.Semantic proximity Read ↗

Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer PatientsSemantic proximity Read ↗

The emerging role of cell-free DNA as a molecular marker for cancer managementSemantic proximity Read ↗

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer ManagementSemantic proximity Read ↗

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging TechnologiesSemantic proximity Read ↗

Cell-Free DNA Concentration as a Mutation-Agnostic Readout of Systemic Tumor Burden and Prognosis: A Prospective Analysis of 1,000 PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.